Elite in Plasmacytoma

Didier Bouscary

Paris, FR 
Elite in Plasmacytoma
Paris, FR 
OverviewLocationsClinical Research

Overview

Didier Bouscary practices in Paris, France. Mr. Bouscary is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Plasmacytoma, Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.

His clinical research consists of co-authoring 145 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Plasmacytoma.

Gender
Male

Locations

Paris, France
Other Locations
Tours, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase II Evaluating the Efficacy of the Dual Inhibition of Phosphoinositide 3 Kinase (PI3K)/Akt /Mammalian Target Of Rapamycine (mTOR) Signaling Pathway by PF-05212384 (PKI-587) for Patients With Myeloid Neoplasm Secondary to Chemo-radiotherapy (t-AML/MDS) or de Novo Relapsed or Refractory AML.
Phase II Evaluating the Efficacy of the Dual Inhibition of Phosphoinositide 3 Kinase (PI3K)/Akt /Mammalian Target Of Rapamycine (mTOR) Signaling Pathway by PF-05212384 (PKI-587) for Patients With Myeloid Neoplasm Secondary to Chemo-radiotherapy (t-AML/MDS) or de Novo Relapsed or Refractory AML.
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Phase: Phase 2

145 Total Publications

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.
Journal: Blood
Published: May 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bouscary's expertise for a condition
ConditionClose
View All 42 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile